The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScot.orntl.smll Regulatory News (SST)

Share Price Information for Scot.orntl.smll (SST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,340.00
Bid: 1,340.00
Ask: 1,345.00
Change: 5.00 (0.37%)
Spread: 5.00 (0.373%)
Open: 1,345.00
High: 1,345.00
Low: 1,340.00
Prev. Close: 1,335.00
SST Live PriceLast checked at -
Scottish Oriental Smaller Companies is an Investment Trust

To achieve long-term capital growth by investing in mainly smaller Asian quoted companies with market cap of below USD 3 m, or the equivalent thereof, at the time of investment.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues review on Scottish Oriental Smlr Co

22 Nov 2018 13:29

RNS Number : 2409I
Scottish Oriental Smlr Co Tst PLC
22 November 2018
 

 

London, UK, 22 November 2018

Edison issues review on Scottish Oriental Smaller Companies (SST)

Scottish Oriental Smaller Companies Trust (SST) aims to deliver long-term capital growth from investing in smaller companies listed in Asia ex-Japan. The investment approach is bottom-up to find quality companies with sustainable growth that are reasonably valued. Unconstrained by the benchmark, the well-diversified portfolio of c 60 stocks represents the manager's highest-conviction ideas, with a preference for domestically oriented businesses in less-developed economies, which can benefit from structural growth drivers. SST has a strong, long-term performance track record and over 10 years has delivered an annualised NAV total return of 18.5%. The trust's current 14.9% discount to cum-income NAV is deeper than its three-year average, in part reflecting a more risk-averse market sentiment. There is scope for this discount to narrow should sentiment towards Asian equities, and small-caps in particular, improve.

 

SST's current 14.9% discount to cum-income NAV is wider than the three-year average of 12.9%. The sharp correction in Asian equities has also afflicted most of SST's peers and discounts have widened across the group. There may be scope for the discount to narrow should sentiment towards Asian equities improve.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisoninvestmentresearch.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Helena Coles, +44 (0)20 3077 5700

Mel Jenner, +44 (0)20 3077 5720

investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-investment-research 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRABXBDBRDDBGID
Date   Source Headline
26th Apr 202412:05 pmRNSNet Asset Value(s)
25th Apr 20244:25 pmRNSHolding(s) in Company
25th Apr 202412:15 pmRNSNet Asset Value(s)
24th Apr 202411:36 amRNSNet Asset Value(s)
23rd Apr 20245:34 pmRNSTransaction in Own Shares
23rd Apr 202412:09 pmRNSNet Asset Value(s)
22nd Apr 20245:15 pmRNSTransaction in Own Shares
22nd Apr 202412:39 pmRNSNet Asset Value(s)
19th Apr 202412:50 pmRNSNet Asset Value(s)
18th Apr 20245:07 pmRNSTransaction in Own Shares
18th Apr 202411:47 amRNSNet Asset Value(s)
17th Apr 20245:09 pmRNSTransaction in Own Shares
17th Apr 202412:29 pmRNSNet Asset Value(s)
16th Apr 20245:10 pmRNSTransaction in Own Shares
16th Apr 202412:21 pmRNSNet Asset Value(s)
15th Apr 20245:09 pmRNSTransaction in Own Shares
15th Apr 202412:20 pmRNSNet Asset Value(s)
12th Apr 20244:02 pmRNSHolding(s) in Company
12th Apr 202412:14 pmRNSNet Asset Value(s)
11th Apr 202411:16 amRNSNet Asset Value(s)
10th Apr 20242:41 pmRNSTransaction in Own Shares
10th Apr 202411:56 amRNSNet Asset Value(s)
9th Apr 20241:06 pmRNSNet Asset Value(s)
9th Apr 20247:00 amRNSHalf-year Report
8th Apr 202412:31 pmRNSNet Asset Value(s)
5th Apr 202412:26 pmRNSNet Asset Value(s)
4th Apr 202412:26 pmRNSNet Asset Value(s)
3rd Apr 20244:56 pmRNSTransaction in Own Shares
3rd Apr 202412:42 pmRNSNet Asset Value(s)
2nd Apr 20245:18 pmRNSTransaction in Own Shares
2nd Apr 202412:56 pmRNSNet Asset Value(s)
2nd Apr 202411:19 amRNSTotal Voting Rights
28th Mar 20244:13 pmRNSTransaction in Own Shares
28th Mar 202411:24 amRNSNet Asset Value(s)
27th Mar 202411:04 amRNSNet Asset Value(s)
26th Mar 202411:24 amRNSNet Asset Value(s)
25th Mar 20244:47 pmRNSTransaction in Own Shares
25th Mar 202412:27 pmRNSNet Asset Value(s)
22nd Mar 20245:17 pmRNSTransaction in Own Shares
22nd Mar 202411:40 amRNSNet Asset Value(s)
21st Mar 202412:57 pmRNSNet Asset Value(s)
20th Mar 202412:08 pmRNSNet Asset Value(s)
19th Mar 20245:01 pmRNSTransaction in Own Shares
19th Mar 202412:01 pmRNSNet Asset Value(s)
18th Mar 202411:51 amRNSNet Asset Value(s)
15th Mar 20245:12 pmRNSTransaction in Own Shares
15th Mar 202412:38 pmRNSNet Asset Value(s)
14th Mar 20245:05 pmRNSTransaction in Own Shares
14th Mar 202412:42 pmRNSNet Asset Value(s)
13th Mar 202412:53 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.